首页> 外文OA文献 >Seroreversion of the serological tests for syphilis in the newborns born to treated syphilitic mothers.
【2h】

Seroreversion of the serological tests for syphilis in the newborns born to treated syphilitic mothers.

机译:经治疗的梅毒母亲所生新生儿的梅毒血清学检测血清逆转。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND--IgG antibodies from mothers adequately treated for syphilis can cross the placenta and appear in the sera of healthy newborns without infection. In such infants, a false diagnosis of congenital syphilis is often made. We have designed a retrospective survey to determine the time of seroreversion of the serological tests for syphilis (STS) in uninfected newborns born to mothers who were adequately treated for syphilis. MATERIALS AND METHODS--Fifty two seropositive, untreated newborns born to 51 mothers treated for syphilis were studied. The newborns were followed at 1, 3, 6, 9, and 12 months of age until seroreversion was detected. The VDRL test was followed until 12 months in 12 of the 22 newborns who were positive at birth, the TPHA in 21 of the 46 newborns, and the FTA-ABS test in 22 of the 48 newborns. RESULTS--In the first serological tests done within 1 month after birth, the VDRL was positive in 22 newborns (42%), the TPHA in 46 (88%), and FTA-ABS in 48 (92%). The VDRL seroreverted within 6 months after birth in 84%, and within 1 year in 100%. The TPHA test seroreverted in 95% within 1 year after birth. The FTA-ABS test seroreverted in 100% within 1 year after birth. CONCLUSIONS--In most seropositive, untreated newborns born to treated mothers the VDRL became negative within 6 months after birth and the TPHA and FTA-ABS within 1 year. This result is consistent with current Centers for Disease Control (CDC) guidelines. However, although the CDC guidelines are adequate in general, we think that some revision is desirable concerning the IgM test and combination of the test results in order to rule out congenital syphilis in seropositive, nonsymptomatic newborns born to the treated mothers.
机译:背景技术-来自经过充分梅毒治疗的母亲的IgG抗体可以穿过胎盘并出现在健康新生儿的血清中而没有感染。在此类婴儿中,经常会做出对先天性梅毒的错误诊断。我们设计了一项回顾性调查,以确定在接受梅毒治疗的母亲所生的未感染新生儿中,梅毒血清学检测(STS)的血清逆转时间。材料与方法-研究了51位接受梅毒治疗的母亲所生的52例未接受血清反应阳性的新生儿。分别在1、3、6、9和12个月大时追踪新生儿,直到检测到血清反转。在22例出生时呈阳性的新生儿中,进行VDRL测试直至12个月,在46例新生儿中的21例中进行了TPHA,在48例新生儿中的22例中进行了FTA-ABS测试。结果-在出生后1个月内进行的首次血清学检查中,VDRL阳性22例(42%),TPHA阳性46例(88%),FTA-ABS阳性48例(92%)。出生后6个月内,VDRL的血清比例为84%,一年内为100%。 TPHA测试在出生后1年内有95%的血清水平下降。出生后1年内,FTA-ABS测试的血清检出率为100%。结论-在大多数血清阳性,未经治疗的母亲中,经治疗的母亲所生的VDRL在出生后6个月内变为阴性,而TPHA和FTA-ABS在1年内变为阴性。该结果与当前的疾病控制中心(CDC)指南一致。但是,尽管CDC指南总体而言是足够的,但我们认为需要对IgM测试和测试结果的组合进行一些修订,以排除接受治疗的母亲所生的血清阳性,无症状新生儿的先天梅毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号